Boothbay Fund Management’s Immune Design Corp. IMDZ Stock Holding History

Boothbay Fund Management’s Portfolio IMDZ Stock Details IMDZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-600	Closed	-$234K	–	1009
2017 Q4	$234K	Buy	+600	New	+$3.27K	0.03%	530

Boothbay Fund Management's IMDZ Position: Q2 2019 in Review

Boothbay Fund Management sold out of Immune Design Corp. (IMDZ) in Q2 2019, closing a stake of 27,122 shares — an estimated $159K sold.

Boothbay Fund Management first reported a position in IMDZ in Q2 2018 and held it in 4 quarters. The position peaked at $159K in Q1 2019. 0 funds tracked by Wall St. Rank hold IMDZ as of Q2 2019.

Boothbay Fund Management reported no remaining Immune Design Corp. position as of Q2 2019 after selling out during the quarter.
Boothbay Fund Management sold 27,122 Immune Design Corp. shares in Q2 2019, an estimated $159K.
Boothbay Fund Management first reported a position in Immune Design Corp. in Q2 2018 and held it in 4 quarters.
Boothbay Fund Management's Immune Design Corp. position peaked at $159K in Q1 2019.
0 funds tracked by Wall St. Rank held Immune Design Corp. as of Q2 2019.

Based on Boothbay Fund Management's 13F filing for Q2 2019, filed 14 Aug 2019.